Avoro Capital Advisors LLC Rocket Pharmaceuticals, Inc. Transaction History

Avoro Capital Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$11.35 - $18.82 $13.6 Million - $22.6 Million	1,200,000 New	1,200,000 $15.1 Million
Q4 2023 Feb 14, 2024	BUY	$16.78 - $31.94 $182,902 - $348,146	10,900 Added 0.87%	1,260,900 $37.8 Million
Q3 2023 Nov 14, 2023	BUY	$15.07 - $24.05 $18.8 Million - $30.1 Million	1,250,000 New	1,250,000 $25.6 Million
Q4 2019 Feb 14, 2020	SELL	$11.07 - $24.23 $3.16 Million - $6.92 Million	-285,714 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$15.0 - $19.81 $4.29 Million - $5.66 Million	285,714 New	285,714 $4.29 Million

224

105M

437K

117K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $220M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.